Binding of mannan-binding protein to various bacterial pathogens of meningitis
- 1 September 1994
- journal article
- Published by Oxford University Press (OUP) in Clinical and Experimental Immunology
- Vol. 97 (3) , 411-416
- https://doi.org/10.1111/j.1365-2249.1994.tb06103.x
Abstract
SUMMARY: Mannan-binding protein (MBP), a calcium-dependent plasma lectin, may play a role in the innate defence against microorganisms. After binding lo carbohydrate structures at the bacterial surface, MBP activates the classical pathway of the complement system. To investigate the binding capacity of MBP to various bacteria associated with meningitis, an assay was developed to study the binding of MBP to bacteria grown in a semisynthetic fluid culture medium. Salmonella montevideo (containing a mannose-rich lipopolysaccharide (LPS)), used as a positive control strain, showed binding of radiolabelled MBP at a level of 80% compared with binding of MBP to zymosan. Binding of labelled MBP to Salm. montevideo was time-dependent, temperature-dependent and saturable. The binding, was inhibited by unlabelled MBP., by mannose and by N-acetyl-o-glucosamine. Among bacterial pathogens often found to cause meningitis, a wide range of MBP binding capacities could be determined. The encapsulated Neisseria meningitidis (representatives from 11 serogroups other than group A were included: n = 22), N. mucosa (n = 1), Haemophilus influenzae type b (n = 10) and Streptococcus agalactiae (n = 5) had a low MBP binding capacity of 21.7% (95% confidence interval (Cl) 3.3–40.1%). Escherichia coli K1 (n = 11). Strep, suis (n = 5), Strep, pneumoniae (n = 10) and N. meningitidis scrogroup A (n = 2) showed intermediate MBP binding capacity of 58.4% (95% Cl 40.0–76.8%). A third group consisting of non-encapsulated Listeria monocytogenes (n = 11), non-encapsulated H. influenzae (n = 2), non-encapsulated N. meningitidis (n = 2), N. cinera (n = 1) and N. subflava (n = 1) strains had a high MBP binding capacity of 87.5% (95% CI 62.5–12.5%). The majority of encapsulated pathogens causing bacterial meningitis seem to have a rather low MBP binding capacity.Keywords
This publication has 22 references indexed in Scilit:
- Characterization studies on a new lectin found in seeds of Vicia erviliaPublished by Wiley ,2001
- Collectins: collagenous C-type lectins of the innate immune defense systemImmunology Today, 1994
- Human Serum Mannose Binding Protein (MBP): Development of an Enzyme-Linked Immunosorbent Assay (ELISA) and Determination of Levels in Serum from 1085 Normal Japanese and in Some Body FluidsBiochemical Medicine and Metabolic Biology, 1993
- A Low Serum Concentration of Mannan‐Binding Protein is Not Associated with Serogroup B or C Meningococcal DiseaseScandinavian Journal of Immunology, 1993
- The level of mannan-binding protein regulates the binding of complement-derived opsonins to mannan and zymosan at low serum concentrationsClinical and Experimental Immunology, 1990
- COMPLEMENT DEFICIENCIES IN PATIENTS OVER TEN YEARS OLD WITH MENINGOCOCCAL DISEASE DUE TO UNCOMMON SEROGROUPSThe Lancet, 1989
- The human mannose-binding protein functions as an opsonin.The Journal of Experimental Medicine, 1989
- A human mannose-binding protein is an acute-phase reactant that shares sequence homology with other vertebrate lectins.The Journal of Experimental Medicine, 1988
- Protein and cell membrane iodinations with a sparingly soluble chloroamide, 1,3,4,6-tetrachloro-3a,6a-diphenylglycolurilBiochemical and Biophysical Research Communications, 1978
- Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4Nature, 1970